These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26738608)

  • 1. Central nervous system EBV lymphoproliferative disorder in a patient with rhabdomyosarcoma.
    Nakashima K; Kodama Y; Nishikawa T; Nishimura M; Ito N; Fukano R; Nomura Y; Ueba T; Inoue T; Oshima K; Okamura J; Inagaki J
    Pediatr Int; 2016 May; 58(5):388-390. PubMed ID: 26738608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Intracranial Methotrexate-associated Lymphoproliferative Disorder without Epstein-Barr Virus Infection Using Rituximab, Methotrexate, Procarbazine, and Vincristine: A Case Report.
    Mizushima M; Ishi Y; Ikeda H; Echizenya I; Otsuka T; Mitsuhashi T; Yamaguchi S; Fujimura M
    NMC Case Rep J; 2022; 9():237-242. PubMed ID: 36061907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study on Epstein-Barr Virus-Positive Mucocutaneous Ulcer and Methotrexate-Associated Lymphoproliferative Disorders Developed in the Oral Mucosa: A Case Series of 10 Patients and Literature Review.
    Obata K; Okui T; Ono S; Umemori K; Ryumon S; Ono K; Yao M; Yoshioka N; Ibaragi S; Sasaki A
    Diagnostics (Basel); 2021 Jul; 11(8):. PubMed ID: 34441310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
    Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
    Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
    Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of systemic and central nervous system post-transplant lymphoproliferative disorder without the use of high-dose methotrexate or radiation.
    Mahapatra S; Chin CC; Iagaru A; Heerema-McKenney A; Twist CJ
    Pediatr Blood Cancer; 2014 Nov; 61(11):2107-9. PubMed ID: 25066638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative disorder with pathological fracture of the femur in a patient with rheumatoid arthritis treated with methotrexate: A case report.
    Oebisu N; Hoshi M; Ieguchi M; Iwai T; Tanaka S; Osawa M; Nakamura H
    Mol Clin Oncol; 2018 Aug; 9(2):187-191. PubMed ID: 30101019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
    Yamakawa N; Fujimoto M; Kawabata D; Terao C; Nishikori M; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Ohmura K; Fujii T; Kitano T; Kondo T; Yurugi K; Miura Y; Maekawa T; Saji H; Takaori-Kondo A; Matsuda F; Haga H; Mimori T
    J Rheumatol; 2014 Feb; 41(2):293-9. PubMed ID: 24334644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder.
    Ueno H; Ohno N; Abe T; Kimoto K; Matsuoka C; Giga M; Naito H; Kono T; Takasu M; Kidani N; Yamasaki R; Ichimura K; Nomura E
    Intern Med; 2022 Dec; 61(24):3733-3738. PubMed ID: 35598995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first case of methotrexate-associated lymphoproliferative disorder in the sacrum: a case report.
    Yamaguchi Y; Morimoto T; Toda Y; Tsukamoto M; Yoshihara T; Hirata H; Kobayashi T; Mawatari M
    BJR Case Rep; 2024 Jan; 10(1):uaae002. PubMed ID: 38352263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous methotrexate-related T-cell lymphoproliferative disorder with CD4, CD30, CD56, EBV-positive tumor cell infiltration: a case illustration and a brief review.
    Omori I; Kawanabe R; Hashimoto Y; Mitsui A; Kodama K; Nogi S; Tsuno H; Horita A; Saito I; Ohmatsu H
    Am J Blood Res; 2021; 11(2):163-167. PubMed ID: 34079630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Central Nervous System Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis: Case Report and Review of Literature.
    Uneda A; Hirashita K; Kanda T; Yunoki M; Yoshino K; Kurozumi K; Date I
    NMC Case Rep J; 2020 Jul; 7(3):121-127. PubMed ID: 32695560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic immunodeficiency-associated lymphoproliferative disorders of the central nervous system: a treatment paradox.
    Tadipatri R; Ekhator C; Narayan R; Azadi A; Yuen KCJ; Grewal J; Fonkem E
    Neurooncol Pract; 2023 Apr; 10(2):169-175. PubMed ID: 36970173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
    Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
    J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-associated lymphoproliferative disorder arising in the retromolar triangle and lung of a patient with rheumatoid arthritis.
    Kudoh M; Harada H; Matsumoto K; Sato Y; Omura K; Ishii Y
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):e105-10. PubMed ID: 24811204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
    Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
    J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy.
    Johnston A; Salles G; Espinouse D; Felman P; André P; Berger F; Coiffier B
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):356-8. PubMed ID: 19064401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases.
    Koens L; Senff NJ; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2014 Jul; 38(7):999-1006. PubMed ID: 24805861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.